岭南健脾生髓膏方联合促红细胞生成素治疗肿瘤相关性贫血的效果观察

发布时间：2019-02-28 10:29

【摘要】：目的评价岭南健脾生髓膏(简称"岭南膏方")联合促红细胞生成素治疗肿瘤相关性贫血的疗效。方法采用前瞻、随机、对照研究方法,将111例肿瘤相关性贫血患者分为观察组51例和对照组60例。观察组:以岭南膏方联合促红细胞生成素治疗,21 d为1个疗程,共2个疗程。对照组:以促红细胞生成素治疗,21 d为1个疗程,共2个疗程。结果在中重度肿瘤相关性贫血患者中,观察组患者RBC、Hb及贫血生命质量测定量表评分、体力疲劳积分改善,输血频次降低,差异有统计学意义(P0.05)。结论岭南膏方联合促红素治疗中重度肿瘤相关性贫血患者有一定疗效,可改善患者生存质量,降低输血频次,是其不错的治疗选择。
[Abstract]:Objective To evaluate the efficacy of combined erythropoietin ("Lingnan paste square") combined with erythropoietin in the treatment of tumor-related anemia. Methods 111 cases of tumor-related anemia were divided into the observation group (51 cases) and the control group (60 cases) by a prospective, random and control method. Observation group: The treatment of erythropoietin with Lingnan ointment,21 days as a course of treatment, and 2 courses of treatment. The control group was treated with erythropoietin, and 21 d was a course of treatment. Results In the patients with moderate to severe tumor-related anemia, the scores of RBC, Hb and the life quality of anemia, the improvement of physical fatigue score, the decrease of blood transfusion frequency and the difference of blood transfusion frequency were observed in the patients with moderate to severe tumor-related anemia (P0.05). Conclusion Lingnan ointment can improve the quality of life of patients and reduce the frequency of blood transfusion, and it is a good choice for treatment of patients with moderate to severe tumor-related anemia.
【作者单位】：广州中医药大学第一附属医院肿瘤中心;澳门科技大学中医药学院;广州中医药大学第三附属医院医务科;
【基金】：广东省中医药局建设中医药强省科研课题(编号:20141082)
【分类号】：R556;R730.5

【相似文献】